Source: International Congress 2017 – Precision medicine approaches in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
Avrum Spira (Boston, United States of America). What can we learn from the biology of premalignant neoplasia for cancer prevention?. International Congress 2017 – Precision medicine approaches in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Pre-invasive diseases of the lung Source: Eur Respir Mon; 2009: 44: 36–56 Year: 2009 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect Source: ISSN=ISSN 1810-6838, ISBN=, page=339 Year: 2006 In whom could we diagnose second primary lung cancers ‘early’? Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013 Implications of new lung adenocarcinoma classification for oncologists Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Immunology-based therapeutic strategies in lung cancer and mesothelioma Source: International Congress 2014 – Beyond tyrosine kinase inhibition: promising new developments in molecular oncology Year: 2014 Classification, epidemiology, and natural history of very early lung cancer Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005 Pathology and molecular biology of lung cancer Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer Year: 2006 Complexity of diagnostics of complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009 Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies Source: International Congress 2019 – State of the art session: Thoracic oncology Year: 2019